$561.00
Catalog Number: CP1100
This assay employs a quantitative chromogenic activity technique that measures the specified antigen in samples.
Product Size:96 Well Plate
| Format | Chromogenic Activity Assay |
|---|---|
| Entrez Gene | 5054 |
| Range | 0.625-20 AU/ml |
| Samples Type | Cell Culture Supernatants, Plasma, Serum |
| Associated Disease | Cancer |
| Species | Human |
| UniProt | P05121 |
| Storage | Refer to component labels for details |
| Application | Assay |
| Plex | 1 |
| Usage | For Research Use Only, Not To Be Used For Diagnostic Purposes |
Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis.
Plasminogen Activator Inhibitor 1 (PAI-1) and Haematologic Parameters in HIV- Positive Patients on Protease Inhibitor-Based HAART Regimen: A Case-Control Study
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-β and TNF-α in mononuclear cells by insulin sensitizing drugs
Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation
TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells
Effect of moderate wine consumption on the activity of enzymes involved in Platelet Activating Factor metabolism and thrombotic biomarkers: A randomized, single-blind, parallel, clinical study in coronary heart disease men patients
Consumption of yogurt enriched with polar lipids from olive oil by-products reduces platelet sensitivity against platelet activating factor and inflammatory indices: A randomized, double-blind clinical trial
Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice
Loading data...